Total reported value
$1.8B
Reporting period: 2026-03-31 · Number of holdings: 26
NEA Management Company, LLC disclosed 26 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $1.8B and a quarterly turnover rate of 52.0%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "N"
Add ACLXGBX
0.0% $151.1M
Trim CELC
-35.4% -$91.8M
Trim GOSS
-94.5% -$55.8M
Trim ZBIO
+14.2% -$49.3M
Add ORIC
0.0% $18.5M
Add GLUE
0.0% $5.9M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 19.88% | +9.76% | — | |
| 2 | CELC | Celcuity INC | Stock-Other | 14.83% | -3.15% | -35.36% | |
| 3 | SGP | Spyglass Pharma INC | Stock-Other | 10.89% | +10.89% | NEW | |
| 4 | TRVI | Trevi Therapeutics INC | Stock-Other | 8.97% | +0.53% | — | |
| 5 | SVRA | Savara INC | Stock-Other | 7.60% | +0.08% | — | |
| 6 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 7.19% | +1.04% | — | |
| 7 | MBX | Mbx Biosciences INC | Stock-Other | 6.13% | +0.32% | — | |
| 8 | ZBIO | Zenas Biopharma INC | Stock-Other | 4.47% | -2.05% | +14.19% | |
| 9 | COUR | Coursera INC | Stock-Other | 4.26% | -0.57% | — | |
| 10 | AUPH | Aurinia Pharmaceuticals INC | Stock-Other | 3.34% | +0.11% | — | |
| 11 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 2.97% | +1.25% | — | |
| 12 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 2.86% | +0.03% | — | |
| 13 | PHAT | Phathom Pharmaceuticals INC | Stock-Other | 1.24% | -0.42% | — | |
| 14 | CVRX | Cvrx INC | Stock-Other | 1.09% | +0.36% | — | |
| 15 | KRRO | Korro Bio INC | Stock-Other | 0.84% | +0.39% | +18.99% | |
| 16 | ASNSUSD | X4 Pharmaceuticals INC | Stock-Other | 0.76% | +0.10% | — | |
| 17 | CSBR | Champions Oncology INC | Stock-Other | 0.56% | -0.04% | — | |
| 18 | BDTX | Black Diamond Therapeutics I | Stock-Other | 0.54% | -0.01% | — | |
| 19 | IVA | Inventiva SA - Adr | Stock-Other | 0.46% | +0.11% | — | |
| 20 | NKTX | Nkarta INC | Stock-Other | 0.43% | +0.09% | — | |
| 21 | LONA | Leonabio INC | Stock-Other | 0.27% | +0.09% | — | |
| 22 | ✓ | Senti Biosciences INC | Stock-Other | 0.17% | -0.03% | — | |
| 23 | MRKR | Marker Therapeutics INC | Stock-Other | 0.12% | — | — | |
| 24 | OKUR | Onkure Therapeutics Inc-a | Stock-Other | 0.11% | +0.04% | — | |
| 25 | GOSS | Gossamer Bio INC | Stock-Other | 0.02% | -2.84% | -94.47% | |
| 26 | IMA | Imagenebio INC | Stock-Other | 0.01% | -0.01% | — |
Performance for Q3 2026
+1.5%
Performance Last 4 Quarters
-6.9%
Based on 53% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 26 | $1.8B | 52 | |
| 2025-12-31 | 27 | $2.0B | 56 | |
| 2025-09-30 | 29 | $1.8B | 56 | |
| 2025-06-30 | 32 | $1.3B | 0 | |
| 2025-03-31 | 38 | $1.3B | 100 | |
| 2024-12-31 | 42 | $1.8B | 0 | |
| 2024-09-30 | 42 | $1.8B | 0 | |
| 2024-06-30 | 41 | $1.3B | 0 | |
| 2024-03-31 | 44 | $1.6B | 0 | |
| 2023-12-31 | 44 | $1.5B | 0 | |
| 2023-09-30 | 46 | $1.3B | 0 | |
| 2023-06-30 | 44 | $1.3B | 0 | |
| 2023-03-31 | 53 | $1.4B | 0 | |
| 2022-12-31 | 57 | $1.8B | 0 | |
| 2022-09-30 | 57 | $2.0B | 0 | |
| 2022-06-30 | 57 | $1.9B | 0 | |
| 2022-03-31 | 57 | $3.5B | 0 | |
| 2021-12-31 | 58 | $4.9B | 0 | |
| 2021-09-30 | 63 | $8.4B | 0 | |
| 2021-06-30 | 63 | $7.7B | 73 | |
| 2021-03-31 | 58 | $4.5B | 49 | |
| 2020-12-31 | 57 | $3.8B | 68 | |
| 2020-09-30 | 54 | $2.4B | 41 | |
| 2020-06-30 | 46 | $2.5B | 66 | |
| 2020-03-31 | 50 | $1.9B | 45 | |
| 2019-12-31 | 47 | $2.1B | 63 | |
| 2019-09-30 | 46 | $1.2B | 53 | |
| 2019-06-30 | 44 | $1.4B | 57 | |
| 2019-03-31 | 45 | $1.9B | 55 | |
| 2018-12-31 | 46 | $2.5B | 67 | |
| 2018-09-30 | 44 | $2.3B | 35 | |
| 2018-06-30 | 43 | $2.1B | 30 | |
| 2018-03-31 | 43 | $2.2B | 35 | |
| 2017-12-31 | 43 | $2.4B | 42 | |
| 2017-09-30 | 44 | $2.9B | 26 | |
| 2017-06-30 | 44 | $2.7B | 26 | |
| 2017-03-31 | 38 | $2.9B | 25 | |
| 2016-12-31 | 39 | $2.5B | 36 | |
| 2016-09-30 | 39 | $2.2B | 22 | |
| 2016-06-30 | 39 | $1.9B | 46 | |
| 2016-03-31 | 37 | $1.5B | 38 | |
| 2015-12-31 | 34 | $1.6B | 38 | |
| 2015-09-30 | 35 | $1.5B | 34 | |
| 2015-06-30 | 34 | $1.9B | 33 | |
| 2015-03-31 | 36 | $2.2B | 38 | |
| 2014-12-31 | 35 | $2.1B | 29 | |
| 2014-09-30 | 35 | $2.0B | 33 | |
| 2014-06-30 | 31 | $2.1B | 33 | |
| 2014-03-31 | 28 | $2.0B | 35 | |
| 2013-12-31 | 29 | $2.1B | 27 | |
| 2013-09-30 | 31 | $2.5B | 35 | |
| 2013-06-30 | 31 | $2.2B | 0 |
NEA Management Company, LLC's most significant position changes for 2026-03-31: Sold out: Rhythm Pharmaceuticals INC (RYTM); New buy: Spyglass Pharma INC (SGP); Sold out: Synlogic INC (SYBX); Trim: Celcuity INC (CELC) — shares -35.36%; Trim: Gossamer Bio INC (GOSS) — shares -94.47%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | +9.8% | — | Unchanged |
| 2 | ORIC | Oric Pharmaceuticals INC | +1.3% | — | Unchanged |
| 3 | GLUE | Monte Rosa Therapeutics INC | +1% | — | Unchanged |
| 4 | TRVI | Trevi Therapeutics INC | +0.5% | — | Unchanged |
| 5 | KRRO | Korro Bio INC | +0.4% | +18.99% | Add |
| 6 | CVRX | Cvrx INC | +0.4% | — | Unchanged |
| 7 | MBX | Mbx Biosciences INC | +0.3% | — | Unchanged |
| 8 | AUPH | Aurinia Pharmaceuticals INC | +0.1% | — | Unchanged |
| 9 | IVA | Inventiva SA - Adr | +0.1% | — | Unchanged |
| 10 | ASNSUSD | X4 Pharmaceuticals INC | +0.1% | — | Unchanged |
| 11 | LONA | Leonabio INC | +0.1% | — | Unchanged |
| 12 | NKTX | Nkarta INC | +0.1% | — | Unchanged |
| 13 | SVRA | Savara INC | +0.1% | — | Unchanged |
| 14 | OKUR | Onkure Therapeutics Inc-a | 0% | — | Unchanged |
| 15 | CRSP | CRISPR Therapeutics AG | 0% | — | Unchanged |
| 16 | MRKR | Marker Therapeutics INC | — | — | Unchanged |
| 17 | BDTX | Black Diamond Therapeutics I | 0% | — | Unchanged |
| 18 | IMA | Imagenebio INC | 0% | — | Unchanged |
| 19 | ✓ | Senti Biosciences INC | 0% | — | Unchanged |
| 20 | CSBR | Champions Oncology INC | 0% | — | Unchanged |
| 21 | PHAT | Phathom Pharmaceuticals INC | -0.4% | — | Unchanged |
| 22 | COUR | Coursera INC | -0.6% | — | Unchanged |
| 23 | ZBIO | Zenas Biopharma INC | -2.1% | +14.19% | Add |
| 24 | GOSS | Gossamer Bio INC | -2.8% | -94.47% | Trim |
| 25 | CELC | Celcuity INC | -3.2% | -35.36% | Trim |
| 26 | RYTM | Rhythm Pharmaceuticals INC | — | EXIT | Sold out |
| 27 | SGP | Spyglass Pharma INC | — | NEW | New buy |
| 28 | SYBX | Synlogic INC | — | EXIT | Sold out |
Institutions with a similar AUM
CIK 0001103887
Total reported value
$1.8B
52 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001357867
Total reported value
$1.8B
72 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001483738
Total reported value
$1.8B
42 stks
2024-09-30
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0000078003
Total reported value
$238.8M
21 stks
2026-03-31
1 of the top 5 holdings overlap, including Celcuity INC
CIK 0000882095
Total reported value
$2.1B
6 stks
2026-03-31
1 of the top 5 holdings overlap, including Arcellx INC
CIK 0001143261
Total reported value
$187.1M
81 stks
2026-03-31
1 of the top 5 holdings overlap, including Arcellx INC